Data through FY2026 Q3 (Jun 30, 2026)
Corcept Therapeutics, Inc
Company profile for Corcept Therapeutics, Inc covers 10 filings across the reporting window. FY2026 certified median offer: $217,419.
- FY2026 certified median
- $217,419
- Total filings
- 10
- FY2026 25th–75th percentile
- $203,709–$231,128
- Top job title
- Senior Director, Commercial Analytics
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 4 | $210,000 | $190,000 | $218,000 |
| FY2025 | 4 | $194,376 | $188,885 | $206,747 |
| FY2026 (Q1–Q3) | 2 | $217,419 | $203,709 | $231,128 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Senior Director, Commercial Analytics2 filings
- Associate Director, Clinical Data Management1 filings
- Associate Director, Manufacturing1 filings
- Associate Director, Statistical Programming1 filings
- Director, Clinical Patient Safety & PV Ops1 filings
- Medical Director, Drug Safety1 filings
- Senior Manager, Statistical Programming1 filings
- Senior Manager, Statistics1 filings
- Sr Manager, Regulatory Affairs (Operations)1 filings
Top cities
- Redwood City8 filings
- Menlo Park1 filings
- Tracy1 filings